护理学报 ›› 2021, Vol. 28 ›› Issue (6): 17-21.doi: 10.16460/j.issn1008-9969.2021.06.017
急性缺血性脑卒中患者静脉溶栓后出血转化预测模型的研究进展
周田田1, 黄萍1, 邹圣强2
- 1.南京大学医学院附属鼓楼医院 急诊科,江苏 南京210008;
2.江苏大学附属镇江三院 重症医学科,江苏 镇江 212005
摘要： 目的 总结目前国内外关于急性缺血性脑卒中患者静脉溶栓后出血转化的预测模型,为今后开展相关研究提供参考依据。方法 计算机检索PubMed、Web of Science、Sciencedirect、Scopus、中国知网、万方等数据库中关于急性缺血性脑卒中患者静脉溶栓后出血转化预测模型的文献,并进行分析与汇总,检索时限为建库至2020年6月。结果 最终检索并总结9个预测模型,其中国外有iScore模型、SEDAN模型、THRIVE模型、SITS模型、STARTING-SICH模型、SICH SCORE模型共6种,国内有THRIVE-c模型、Xu团队的模型、常红团队的模型共3种。结论 国内外目前关于急性脑卒中患者溶栓后发生出血转化的预测模型各有优缺点,国内应在学习国外风险预测模型研究的基础上,进一步探索我国急性脑卒中患者溶栓后发生出血的风险因素并构建模型,从而为高危人群筛查和早期干预提供科学依据。
中图分类号:
- R473.74
| [1] Benjamin EJ, Blaha MJ, Chiuve SE, et al.Heart Disease and Stroke Statistics-2017 Update:A Report from the American Heart Association[J].Circulation,2017, 135(10):e146-e603. DOI:10.1161/CIR.0000000000000485. [2] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志, 2018,51(9):666-682. DOI:10.3760/cma.j.issn.1006-7876.2018.09.004. [3] Wardlaw JM, Murray V, Berge E, et al.Recombinant Tissue Plasminogen Activator for Acute Ischaemic Stroke:An Updated Systematic Review and Meta-analysis[J].Lancet,2012,379(9834):2364-2372. DOI:10.1016/S0140-6736(12)60738-7. [4] Chen YW, Sung SF,Chen CH, et al.Intravenous Thrombolysis Administration 3-4.5h after Acute Ischemic Stroke: A Retrospective, Multicenter Study[J].Front Neurol,2019,10:1038. DOI:10.3389/fneur.2019.01038. [5] Powers WJ, Rabinstein AA, Ackerson T, et al.Guidelines forthe Early Management of Patients with Acute Ischemic Stroke:2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke:A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association[J].Stroke, 2019,50(12):e344-e418. DOI:10.1161/STR.0000000000000211. [6] Romano JG,Smith EE,Liang L,et al.Outcomes in Mild Acute Ischemic Stroke Treated with Intravenous Thrombolysis:A Retrospective Analysis of the Get with the Guidelines-stroke Registry[J].JAMA Neurol, 2015, 72(4):423-431. DOI:10.1001/jamaneurol.2014.4354. [7] Saposnik G, Kapral MK, Liu Y, et al.iScore:A Risk Score to Predict Death Early after Hospitalization for an Acute Ischemic Stroke[J].Circulation, 2011, 123(7):739-749. DOI: 10.1161/CIRCULATIONAHA.110.983353. [8] Saposnik G, Raptis S, Kapral MK, et al.The iScore Predicts Poor Functional Outcomes Early after Hospitalization for an Acute Ischemic Stroke[J].Stroke, 2011, 42(12):3421-3428. DOI:10.1161/STROKEAHA.111.623116. [9] Saposnik G, Demchuk A, Tu JV,et al.The iScore Predicts Efficacy and Risk of Bleeding in the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Stroke Trial[J].J Stroke Cerebrovasc Dis,2013,22(6):876-882. DOI:10.1016/j.jstrokecerebrovasdis.2012.09.001. [10] Park TH, Park SS,Ko Y,et al.The iScore Predicts Clinical Response to Tissue Plasminogen Activator in Korean Stroke Patients[J].J Stroke Cerebrovasc Dis, 2014,23(2):367-373. DOI:10.1016/j.jstrokecerebrovasdis.2013.05.025. [11] Strbian D,Engelter S,Michel P,et al.Symptomatic Intracranial Hemorrhage after Stroke Thrombolysis: The SEDAN Score[J].Ann Neurol, 2012,71(5):634-641. DOI:10.1002/ana.23546. [12] Al-Khaled M, Langner B, Brüning T.Predicting Risk of Symptomatic Intracerebral Hemorrhage and Mortality after Treatment with Recombinant Tissue-plasminogen Activator Using SEDAN Score[J].Acta Neurol Scand, 2016,133(4):239-244. DOI:10.1111/ane.12447. [13] Flint AC, Cullen SP, Faigeles BS, et al.Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks in Vascular Events Score[J].Am J Neuroradiol,2010,31(7):1192-1196. DOI:10.3174/ajnr.A2050.[14] Flint AC, Kamel H, Rao VA, et al.Validation of the Totaled Health Risks in Vascular Events (THRIVE) Score for Outcome Prediction in Endovascular Stroke Treatment[J].Int J Stroke,2014, 9(1):32-39. DOI10.1111/j.1747-4949.2012.00872.x. [15] Flint AC, Faigeles BS, Cullen SP,et al.THRIVE Score Predicts Ischemic Stroke Outcomes and Thrombolytic Hemorrhage Risk in VISTA[J].Stroke,2013,44(12):3365-3369. DOI:10.1161/STROKEAHA.113.002794. [16] Flint AC, Gupta R, Smith WS, et al.The THRIVE Score Predicts Symptomatic Intracerebral Hemorrhage after Intravenous tPA Administration in SITS-MOST[J].Int J Stroke,2014,9(6):705-710. DOI:10.1111/ijs.12335. [17] Mazya M, Egido JA, Ford GA, et al.Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated with Intravenous Alteplase: Safe Implementation of Treatments in Stroke(SITS) Symptomatic Intracerebral Hemorrhage Risk Score[J].Stroke,2012,43(6):1524-1531. DOI: 10.1161/STROKEAHA.111.644815. [18] Nisar T, Hanumanthu R, Khandelwal P.Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models[J].J Stroke Cerebrovasc Dis,2019,28(11):104360. DOI:10.1016/j.jstrokecerebrovasdis.2019.104360. [19] Cappellari M,Turcato G, Forlivesi S,et al.STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke[J].Stroke,2018,49(2):397-404. DOI:10.1161/STROKEAHA.117.018427. [20] Diedler J, Ahmed N, Sykora M, et al.Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset[J].Stroke,2010,41(2):288-294. DOI:10.1161/STROKEAHA.109.559724. [21] Cucchiara B, Kasner SE, Tanne D, et al.Factors Associated with Intracerebral Hemorrhage after Thrombolytic Therapy for Ischemic Stroke: Pooled Analysis of Placebo Data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials[J].Stroke, 2009,40(9):3067-3072. DOI:10.1161/STROKEAHA.109.554386. [22] Ruecker M, Matosevic B, Willeit P, et al.Subtherapeutic Warfarin Therapy Entails an Increased Bleeding Risk after Stroke Thrombolysis[J].Neurology,2012,79(1):31-38. DOI: 10.1212/WNL.0b013e31825dcdf0. [23] Miedema I, Luijckx GJ, De Keyser J, et al.Thrombolytic Therapy for Ischaemic Stroke in Patients Using Warfarin: A Systematic Review and Meta-analysis[J].J Neurol Neurosurg Psychiatry,2012, 83(5):537-540. DOI:10.1136/jnnp-2011-301794. [24] Xian Y, Liang L, Smith EE, et al.Risks of Intracranial Hemorrhage among Patients with Acute Ischemic Stroke Receiving Warfarin and Treated with IntravenousTissue Plasminogen Activator[J].JAMA,2012,307(24):2600-2608. DOI:10.1001/jama.2012.6756. [25] Lokeskrawee T, Muengtaweepongsa S, Patumanond J, et al.Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score[J].J Stroke Cerebrovasc Dis,2017, 26(11):2622-2629. DOI:10.1016/j.jstrokecerebrovasdis.2017.06.030. [26] Pan Y, Peng Y, Chen W,et al.THRIVE-c Score Predicts Clinical Outcomes in Chinese Patients after Thrombolysis[J].Brain Behav,2018,8(2):e00927. DOI:10.1002/brb3.927. [27] Xu X, Li C, Wan T, et al.Risk Factors for Hemorrhagic Transformation Following Intravenous Thrombolysis in Acute Cerebral Infarction:A Retrospective Single Center Study[J].World Neurosurgery, 2017,101:155-160. DOI:10.1016/j.wneu.2017.01.091. [28] 常红,赵洁,王晓娟,等.急性缺血性脑卒中患者静脉溶栓后出血预警模型的构建[J].中华护理杂志, 2019, 54(11):1648-1652. DOI:10.3761/j.issn.0254-1769.2019.11.010. [29] Wang R, Zeng J, Wang F,et al.Risk Factors of Hemorrhagic Transformation after Intravenous Thrombolysis with rt-PA in Acute Cerebral Infarction[J].QJM, 2019,112(5):323-326. DOI:10.1093/qjmed/hcy292. |
| [1] | 陈俊杉, 范杰梅, 余金甜, 张爱琴. 神经外科ICU患者谵妄风险预测模型的构建与验证[J]. 护理学报, 2021, 28(4): 1-8. |
| [2] | 王亚玲, 王冰寒, 张艳, 尹雪, 蒋辛, 熊晓明, 黎华丽. 急性缺血性脑卒中患者溶栓术后预防出血转化的最佳证据总结[J]. 护理学报, 2021, 28(3): 46-52. |
| [3] | 陈敏, 郑伟琴, 陈华, 蔡文智, 陈玲, 苏丹, 万星阳. 2型糖尿病患者便秘风险列线图预测模型的建立与验证[J]. 护理学报, 2021, 28(2): 58-61. |
| [4] | 武玉洁, 邢乃姣, 韩丽, 刘盼盼, 赵迪, 赵梦璐, 王爱敏. 社区老年人居家不出危险因素分析及风险预测模型构建[J]. 护理学报, 2020, 27(8): 11-15. |
| [5] | 张娟, 黄蓓蓓, 余天浩, 刘夕珍, 顾静. 基于医疗失效模式与效应分析模型的急性缺血性脑卒中患者院内急救流程优化[J]. 护理学报, 2020, 27(4): 16-20. |
| [6] | 孙阳阳, 隋萍, 刘晓红, 董玉娇, 王娅楠. 急性冠脉综合征患者PCI术后1年发生不良心血管事件风险预测模型的构建及评价[J]. 护理学报, 2020, 27(19): 11-16. |
| [7] | 旷小羿, 侯惠如. 基于电子病历数据的风险预测模型在临床护理中的应用现状[J]. 护理学报, 2020, 27(16): 21-24. |
| [8] | 陈俊杉, 余金甜, 赵思雨, 张爱琴. ICU患者谵妄风险预测模型研究进展[J]. 护理学报, 2019, 26(5): 15-19. |
| [9] | 汪云云, 谢小华, 潘璐, 张剑, 邓丽萍, 熊小云, 马家惠, 肖静怡. WORSEN评分预测急性缺血性脑卒中早期神经功能恶化的效能评估[J]. 护理学报, 2019, 26(5): 1-5. |
| [10] | 达志, 季学丽, 张丽. 急性缺血性脑卒中绿色通道信息化建设与应用[J]. 护理学报, 2019, 26(14): 19-21. |
| [11] | 姚秀英, 耿丽, 张理想, 黄蕾, 陈霞, 安曼德. ICU患者压力性损伤预测风险列线图模型的建立[J]. 护理学报, 2019, 26(11): 55-59. |
| [12] | 陈霞,范冬冬,储友群,张连荣. 急性缺血性脑卒中患者静脉溶栓现况及院前延迟的影响因素分析[J]. 护理学报, 2016, 23(21): 1-4. |
|